Brief: Atossa Therapeutics Issues Letter To Shareholders Highlighting 2025 Accomplishments And 2026 Outlook
11/02/2026 13:58
Feb 11 (Reuters) - Atossa Therapeutics Inc ATOS.O: ATOSSA THERAPEUTICS ISSUES LETTER TO SHAREHOLDERS HIGHLIGHTING 2025 ACCOMPLISHMENTS AND 2026 OUTLOOK Source text: ID:nPn4hrgxSa Further company coverage: ATOS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Atossa Therapeutics
See all newsAtossa Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Atossa Therapeutics Q3 net loss narrows as clinical trial expenses decline
Brief: Atossa Therapeutics Executes Contingent Value Rights Agreement Providing Shareholders Participation In Potential Priority Review Voucher Value
US RESEARCH ROUNDUP-Amrize, Dexcom, Lennar
Atossa Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary